Cargando…
Bilateral atypical fractures of the femur: Ten years AFTER ten years of bisphosphonate therapy
BACKGROUND: Atypical femur fracture (AFF) is a clinically important complication of bisphosphonate (BP) use in the treatment of osteoporosis. The benefits of long-term BP therapy in preventing osteoporotic fractures have been shown to outweigh the risks of treatment. Discontinuation of BPs or “drug...
Autores principales: | Smith, Matthew D., Haseman, Olen J., Velez Garza, Jorge A., Bruder, Jan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361289/ https://www.ncbi.nlm.nih.gov/pubmed/34409133 http://dx.doi.org/10.1016/j.bonr.2021.101112 |
Ejemplares similares
-
Bisphosphonates and Atypical Fractures of Femur
por: Yli-Kyyny, Tero
Publicado: (2011) -
Bisphosphonates and atypical subtrochanteric fractures of the femur
por: Kharwadkar, N., et al.
Publicado: (2017) -
A Case Report of Long-Term Bisphosphonate Therapy and Atypical Stress Fracture of Bilateral Femur
por: Jo, Yil Ryun, et al.
Publicado: (2013) -
Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years
por: Lo, Joan C., et al.
Publicado: (2020) -
Bisphosphonates and Atypical Femur Fractures: Is the Relationship Causal or Casual?
por: Bal, Rajeshwaree, et al.
Publicado: (2023)